Back to Search
TAYLOR MOODY, MD
MD
Nephrology Physician
NPI: 1629606637IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
13312662-1205(UT)
CMS Specialties
PrimaryNEPHROLOGY
Education
UNIVERSITY OF KENTUCKY COLLEGE OF MEDICINE
Class of 2020
Research & Publications (20)
Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.
PMID 19628293·Lung Cancer·2010
7-preclinical
Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells.
PMID 17580098·Peptides·2007
7-preclinical
Thymosin alpha1 as a chemopreventive agent in lung and breast cancer.
PMID 17567944·Ann N Y Acad Sci·2007
7-preclinical
Bombesin/gastrin-releasing peptide receptor antagonists increase the ability of histone deacetylase inhibitors to reduce lung cancer proliferation.
PMID 16691010·J Mol Neurosci·2006
7-preclinical
In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors.
PMID 16766720·J Pharmacol Exp Ther·2006
7-preclinical
Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications.
PMID 15134870·Peptides·2004
6-review
Development of high affinity camptothecin-bombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells.
PMID 15016826·J Biol Chem·2004
7-preclinical
VIP receptor antagonists inhibit mammary carcinogenesis in C3(1)SV40T antigen mice.
PMID 14706566·Life Sci·2004
7-preclinical
Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells.
PMID 12909192·Eur J Pharmacol·2003
7-preclinical
Thymosin alpha1 inhibits mammary carcinogenesis in Fisher rats.
PMID 12084534·Peptides·2002
7-preclinical
PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells.
PMID 12409225·Regul Pept·2002
7-preclinical
VIP-ellipticine derivatives inhibit the growth of breast cancer cells.
PMID 12088760·Life Sci·2002
8-other
SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells.
PMID 11179604·Peptides·2001
7-preclinical
CI-988 inhibits growth of small cell lung cancer cells.
PMID 11714907·J Pharmacol Exp Ther·2001
8-other
VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells.
PMID 11678309·Breast Cancer Res Treat·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1100 COUNTY HILLS DR
OGDEN, UT 84403 - Phone
- (801) 387-7900
Quick Facts
- NPI
- 1629606637
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile